Peijia Medical (HKSE:09996) Change In Receivables : HK$0.0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Change In Receivables?

Peijia Medical's change in receivables for the quarter that ended in Jun. 2023 was HK$0.0 Mil. It means Peijia Medical's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Peijia Medical's change in receivables for the fiscal year that ended in Dec. 2022 was HK$0.0 Mil. It means Peijia Medical's Accounts Receivable stayed the same from Dec. 2021 to Dec. 2022 .

Peijia Medical's Accounts Receivable for the quarter that ended in Jun. 2023 was HK$13.4 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Peijia Medical's Days Sales Outstanding for the six months ended in Jun. 2023 was 9.94.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Peijia Medical's liquidation value for the six months ended in Jun. 2023 was HK$850.8 Mil.

Peijia Medical Change In Receivables Historical Data

The historical data trend for Peijia Medical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Change In Receivables Chart

Peijia Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

Peijia Medical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial						-	-	-	-	-

Peijia Medical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Peijia Medical (HKSE:09996) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Peijia Medical's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	13.402	/	245.96	*	91
=	9.94

2. In Ben Graham's calculation of liquidation value, Peijia Medical's accounts receivable are only considered to be worth 75% of book value:

Peijia Medical's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1169.286	-	420.272	+	0.75 * 13.402	+	0.5 * 183.565
=	850.8

Peijia Medical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Peijia Medical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Peijia Medical (HKSE:09996) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN

Website

https://www.peijiamedical.com

Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Executives

Jinnius Drive Trust	2103 Interests held jointly with another person
Xinyue International Limited	2103 Interests held jointly with another person
Ye Hong	2103 Interests held jointly with another person
Zhang Ping Ye	2103 Interests held jointly with another person
Zhang Yi	2301 Trustee
Hanlindale Trust	2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd.	2102 Investment manager
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited	2101 Beneficial owner
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Shi Yi	2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines